Ohio State Navbar

Directory

Todd E. Pesavento, MD


Staff photo

395 W 12th Ave
Columbus, OH 43210

Phone: (614) 293-4997

Email: pesavento.2@osu.edu

 

Current OSU Appointments

Professor-Clinical, Nephrology

Physician, FGP-Nephrology

 

Certifications

present Medical License: State Medical Board of Ohio
1992 - present Board Certification (Diplomate): American Board of Internal Medicine
2004 - present Diplomate: American Board of Nephrology
 

Chapters in Books

Pesavento TE and Falkenhain ME. "Management of Renal Transplant Patients." In Kidney Disease in Primary Care. Edited by Mandal A and Nahman NS, Jr. 241-254. New Delhi, India: Jaypee Brothers, January 1998.

Pesavento TE. "Diagnosis and Management of medical complications of renal transplantation including rejetion." In Textbook of Nephrology for the Asian Pacific Physicians, 2nd edition. Edited by Mandal A and Agarwal AK. 321-332. New Delhi, India: Jaypee Brothers, January 2004.

TE Pesavento. "Postrenal Transplantation Late Complications Including Rejection.." In Textbook of Nephrology Third Edition. Edited by Anil K. Mandal. -. Unknown: Unknown, January 2010.

 

Degrees

1985 B.A., Eastern Kentucky University

1989 M.D., University of Louisville

 

Editorial Activities

present Dialysis and Transplantation
present Dialysis and Transplantation
present Clinical Transplantation
present Clinical Nephrology
present American Journal of Medical Sciences
present American Journal of Kidney Diseases
present Kidney International
present American Society of Nephrology
present American Journal of Transplantation
present Nephron
present Journal of the American Society of Nephrology
present KDIGO - Clinical Practice Guideline for the Care of Kidney Transplant Recipients
present American Transplant Congress
2009 - present Dialysis and Transplantation
 

Honors

2007 America's Best Doctors. U.S. News & World Report.
2008 America's Best Doctors. U.S. News & World Report.
2009 America's Best Doctors. U.S. News & World Report.
2010 America's Best Doctors. U.S. News & World Report.
 

Journal Articles

Pesavento, T, E; Jones, P, A; Julian, B, A; Curtis, J J. "Amlodipine increases cyclosporine levels in hypertensive renal transplant patients: results of a prospective study.." Journal of the American Society of Nephrology : JASN. Vol. 7, no. 6. (January 1996.): 831-5.

Cosio, F, G; Falkenhain, M, E; Pesavento, T, E; Henry, M, L; Elkhammas, E, A; Davies, E, A; Bumgardner, G, L; Ferguson, R M. "Relationships between arterial hypertension and renal allograft survival in African-American patients.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 29, no. 3. (January 1997.): 419-27.

Cosio, F, G; Pesavento, T, E; Sedmak, D, D; Farhan, N; Pelletier, R, P; Henry, M, L; Elkhammas, E, A; Bumgardner, G, L; Ferguson, R M. "Clinical implications of the diagnosis of renal allograft infarction by percutaneous biopsy.." Transplantation. Vol. 66, no. 4. (January 1998.): 467-71.

Cosio, F, G; Elkhammas, E, A; Henry, M, L; Pesavento, T, E; Sedmak, D, D; Pelletier, R, P; Bumgardner, G, L; Ferguson, R M. "Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients.." Transplantation. Vol. 65, no. 1. (January 1998.): 93-9.

Pesavento, T, E; Henry, M, L; Falkenhain, M, E; Cosio, F, G; Bumgardner, G, L; Elkhammas, E, A; Pelletier, R, P; Ferguson, R M. "Obese living kidney donors: short-term results and possible implications.." Transplantation. Vol. 68, no. 10. (January 1999.): 1491-6.

Cosio, F, G; Pelletier, R, P; Sedmak, D, D; Pesavento, T, E; Henry, M, L; Ferguson, R M. "Renal allograft survival following acute rejection correlates with blood pressure levels and histopathology.." Kidney international. Vol. 56, no. 5. (January 1999.): 1912-9.

Cosio, F, G; Frankel, W, L; Pelletier, R, P; Pesavento, T, E; Henry, M, L; Ferguson, R M. "Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.." American journal of kidney diseases : the official journal of the National Kidney Foundation. Vol. 34, no. 4. (January 1999.): 731-8.

Cosio, F, G; Falkenhain, M, E; Pesavento, T, E; Yim, S; Alamir, A; Henry, M, L; Ferguson, R M. "Patient survival after renal transplantation: II. The impact of smoking.." Clinical transplantation. Vol. 13, no. 4. (January 1999.): 336-41.

Cosio, F, G; Pesavento, T, E; Osei, K; Henry, M, L; Ferguson, R M. "Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.." Kidney international. Vol. 59, no. 2. (January 2001.): 732-7.

Cosio, F, G; Pelletier, R, P; Pesavento, T, E; Henry, M, L; Ferguson, R, M; Mitchell, L; Lemeshow, S. "Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients.." Kidney international. Vol. 59, no. 3. (January 2001.): 1158-64.

Wilmer, W, A; Pesavento, T, E; Bay, W, H; Middendorf, D, F; Donelan, S, E; Frabott, S, M; McElligott, R, F; Powell, S L. "Peritoneal dialysis following failed kidney transplantation is associated with high peritoneal transport rates.." Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. Vol. 21, no. 4. (January 2001.): 411-3.

Hariharan S, Pirsch JD, Lu CY, Chan L, Pesavento TE, Alexander S, Baumgardner G, Baasadona G, Hricik DE, Pescovitz MD, Rubin N. "Pancreas after kidney transplantation." Journal of the American Society of Nephrology. Vol. 13, (January 2002.): 1109-1118.

Cosio FG, Pesavento TE, Pelletier RP, Henry ML, Ferguson RM, Kim S, Lemeshow S,. "Patient Survival after Renal Transplantation III: The Effects of Statins." American Journal of Kidney Disease. Vol. 40, (January 2002.): 638-643.

Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. "Patient survival after renal transplantation IV: The impact of post-transplant diabetes." Kidney International. Vol. 62(4), (January 2002.): 1440-1446.

Terrado LT, Wilmer WA, Pesavento TE. "Culture negative peritoneal dialysis peritonitis associated with pancreaticoduodenocystotomy leak of a pancreas transplant." American Journal of Kidney Disease. Vol. 41(6), (January 2003.): E4-8.

Pesavento TE, Henry ML, Falkenhain MF, Ferguson RM. "Post-transplant diabetes mellitus: Evidence for glucose intolerance and insuline resistance existing before transplantation." Transplantation reviews. Vol. 17(4), (January 2003.): S39-.

Spetie DN, Tang Y, Rovin BH, Nadasdy T, Nadasdy G, Pesavento TE, Hebert LA. "Mycophenolate therapy of SLE membranous nephropathy." Kidney International. Vol. 66, (January 2003.): 2411-2415.

Cosio FG, Henry ML, Pesavento TE, Ferguson RM, Kim S, Lemeshow S. "The relationship between donor age and cadaveric renal allograft survival is modified by the recipient's blood pressure." American Journal of Transplantation. Vol. 3, (January 2003.): 340-347.

Pesavento TE, Bay WH, Agarwal G, Hernandez RA, Hebert LA. "Mycophenolate therapy in adults with steroid-responsive frequently relapsing minimal change disease that has failed cyclophosphamide therapy." American Journal of Kidney Disease. Vol. 43, (January 2004.): e3-6.

Pesavento TE, Rave EM, Ferguson RM. "Gastric bypass surgery as treatment of morbid obesity following transplantation." Improvement in weight and metabolic complications. Vol. 5, (January 2005.): supp 11:290-.

Fishman J, Buell J, Arcasoy S, Becker B, Galbraith C, Newell K, Pesavento T. "Healthy Transplant: Infection and Malignancy." American Society of Transplantation http://www.healthytransplant.com/. (January 2006.): -.

Bostom et al. on behalf of the FAVORIT investigators. "Rationale and design of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) trial." American Heart Journal. Vol. 152, no 3, (September 2006.): -.

Satoskar AA, Lehman AM, Nadasdy GM, Sedmak DD, Pesavento TE, Henry ML, Pelletier RP, Ferguson RM, Nadasdy T. "Peritubular capillary C4d staining in late acute renal allograft rejection – it is relevant?." Clin Transplant. (January 2008.): -.

S . Moffatt-Bruce , T . Pesavento , J . Von Viger , D . Nunley , A . Pope-Harman , S . Martin , P . Ross. "Successful Management of Immunosuppression in a Patient with Severe Hyperammonemia after Lung Transplantation." J Heart Lung Transplant. (July 2008.): 801-803.

FAVORIT investigators. "Baseline Characteristics of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial." Am J Kidney Dis. no. 53. (January 2009.): 121-128.

N Singh, U Nori and T Pesavento. "Kidney transplantation in the elderly." Curr Opin Organ Transplant. (August 2009.): 380-5.

Transplant Work Group. "KDIGO clinical practice guideline for the care of kidney transplant recipients." Kidney Disease: Improving Global Outcomes (KDIGO). (November 2009.): S1-155.

Pesavento TE. "Kidney transplantation in the context of renal replacement therapy.." Clin J Am Soc Nephrol. (December 2009.): 2035-9.

Pelletier R, Henry M, Pesavento T, Brodsky S, Nadasdy G, Adams PW, Sataskar A.. "De novo thrombotic microangiopathy in renal allografts - Role of antibody-mediated rejection." American Journal of Transplantation. (January 2010.): -.

Bostom AG, MD, Carpenter MA, Hunsicker L, Jacques PF, Mayer J, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J, Mayer J, For the FAVORIT Study Investigators. "Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial." NEJM. (January 2010.): -.

Martin SI, Dodson B, Wheeler C, Davis J, Pesavento T, Bumargardner GL. "Monitoring Infection with Epstein-Barr Virus Among Seromismatch Adult Renal Transplant Recipients." American Journal of Transplantation. (January 2011.): -.

Nori US, Pesavento TE, Hebert LA. "Measured GFR Has Limited Clinical Utility.." Am J Kidney Dis. Vol. 57, no. 1. (January 2011.): 180-.

Bostom AG, Carpenter MA, Kusek JW… Pesavento TE, et al for the FAVORIT Study Investigators.. "Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial." Circulation. no. 123. (January 2011.): 1763-1770.

 

Reference Works

January 1992 Balkovetz DF, Wang D, Pesavento TE, Kirk KA, Warnock DG."Histidine 349 Mutation to Glycine in Expressed Human NHE-1Specifically Reduces Sensitivity to Amiloride and EIPA" .
January 1994 Pesavento T, Curtis JJ, Jones P."Inaccuracy of the Cockcroft-Gault Formula in Predicting GFR in Renal Transplant Patients" . : 1030
January 1995 Pesavento, TE, Jones PA, Julian BJ, Curtis JJ."Amlodipine Increases Cyclosporine Levels in Renal Transplant Patients" .
January 1996 M.E.Falkenhain, F.G.Cosio, T.E.Pesavento, R.M.Ferguson."Early graft function modulates the risk for acute rejection (AR) and the effect of AR on renal graft survival" . : 1907
January 1996 Cosio FG, C.G. Orosz, T.E. Pesavento, R.M. Ferguson."High levels of serum antibodies to heat shock protein 60 (HSP60) pre-transplant are associated with early graft loss" . : 1904
January 1996 Haddad C, Cosio FG, Pesavento TE, Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Baumgardner G, Ferguson RM."Elevated urine collagen IV levels correlate with the severity of acture renal transplant rejection" Dallas.
January 1996 Cosio FG, S. Yim, M.E. Falkenhain, T.E. Pesavento, M.L. Henry, E.A. Elkhammas, E.A. Davies, G. Baumgartner, R.M. Ferguson."Smoking and left ventricular hypertrophy prior to renal transplantation predict patient survival after Tx" .
January 1997 Cosio FG, Elkhammas EA, Falkenhain ME, Pesavento TE, Pelletier RP, Henry ML, Davies EA, Baumgardner G, Ferguson RM."Renal allograft survival in recipients of combined kidney-pancreas transplants" Chicago.
January 1997 Cosio FG, Alamir A., Falkenhain ME, Pesavento TE, Pelletier RP, Henry ML, Elkhammas EA, Davies EA, Baumgardner G, Ferguson RM."Time on dialysis prior to renal transplantation correlates with patient survival post-Tx" Chicago.
January 1997 Phan LT and Pesavento TE."Spurious Cytoplasmic Anti-Neutrophil Cytoplasmic Antibody (C-ANCA) Positivity in Xanthogranulomatous Pyelonephritis (XGP): A New Association" . : 97A7
January 1997 Pesavento TE, Henry ML, Falkenhain ME, Cosio FG, Davies EA, Bumgardner GL, Elkhammas EA, Pelletier RP, Ferguson RM."Analysis of Complications in Obese Living Kidney Donors" Chicago.
January 1997 Pesavento TE, Farhan NJ, Cosio FG, Falkenhain ME, Elkhammas EA, Fergsuon RM."Predialysis Transplant Evaluation (TxEv) Predialysis Transplant Evaluation Improves Patient Survival in Kidney- Pancreas Transplantation (KPTX)" . : 698A
January 1997 Pesavento TE, Cosio FG,Farhan NJ, Sedmak DD, Falkenhain ME, Ferguson RM."Renal Infarction in Kidney Transplantation" . : 699A
January 1997 Falkenhain ME, Coiso FG, Pesavento T, Sedmak D."Clinical pathological correlates for a new subclassification of chronic allograft nephropathy" . : 682A
January 1997 Donelan SM, Frabott SM, McElligott RF, Powell SL, Middendorf DF, Bay WH, Pesavento TE, Wilmer WA."Peritoneal membrane function of patients receiving CAPD after renal allograft failure" . : 263A
January 1998 Cosio FG, Sedmak DD, Pesavento TE, Pelletier RP, Falkenhain ME, Ferguson RM."De Novo focalsemental glomeruloslcerosis in renal allografts: Implications for graft survival" . : 706A
January 1998 Cosio FG, Pesavento TE, Sedmak DD, Ferguson RM."Focal infarcts of renal allografts: Clinical and prognostic implications" . : 706A
January 1998 Pesavento TE, Pelletier RP, Falkenhain ME, Ferguson RM."Decreased nephron mass is not associated with worsened renal survival, function or proteinuria in living donor renal transplants: A model for future renal transplantion" . : 83
January 1998 Pesavento TE, Falkenhain ME, Cosio FG, Bahnson RR."Renal function after nephrectomy in the elderly and hypertensive: Implications for living donors" . : 255
January 1998 Falkenhain ME, Cosio FG, Pesavento TE, Davies EA, Pelletier RP, Bumgardner GL, Henry ML, Ferguson RM."Low-dose angiotension converting enzyme inhibitors are safe and effective in reducing proteinuria in renal allograft recipients" . : 220
January 1999 Pesavento TE, Pelletier RP, Henry ML, Ferguson RM, Cosio FG."Patient survival after renal transplantation correlates with the use of HMG CoA reductase inhibitors but not with serum lipid levels" . : 742A
January 1999 Pesavento TE, Falkenhain MA, Rovin BH, Hebert LA."Mycophenolate mofetil therapy in anti-neutrophil cytoplasmic antibody vasculitus" . : 114A
January 1999 Pesavento TE, Elkhammas EA, Cosio FG, Becker WJ, Ferguson RM."Proteinuria does not correlate with renal graft survival in kidney-pancreas transplant recipients" . : 742A
January 1999 Pesavento TE, Barnes J, Falkenhain ME, Ferguson RM, Cosio FG."Troglitazone improves hyperlipidemia in diabetic transplant patients" . : S116
January 1999 Falkenhain MA, Pelletier RP, Pesavento TE, Ferguson RM, Cosio FG."Treatment of systemic hypertension early after renal transplantation reduces the risk of acute rejection" . : 756A
January 1999 Falkenhain M, Pesavento TE, Bhatt UY, Nahman NS, Hebert LA."Limiting dietary protein intake is ineffective in lowering plasma homocysteine levels in patients with renal insuffiency" . : 163A
January 1999 Cosio FG, Pelletier RP, Pesavento TE, , Falkenhain ME, Ferguson RM."Elevated blood pressure levels predict the risk of acute rejection after renal translantation" . : S28
January 1999 Logar C, Pesavento T, Nahman Jr, NS."Clinical effect of moderate cyclophosphamide doses in pauci-immune ANCA-associated vasculitis in patients with advance renal insuffiency" . : 109A
January 2000 Pesavento TE, Pelletier RP, Henry ML, Ferguson RM, Cosio FC."Improved patient survival in high risk renal transplant recipients treated with HMG CoA reductase inhibitors: An effect independent of serum lipid levels" . : S365
January 2000 Pesavento TE, Cosio FC, Falkenhain ME, Elkhammas EA, Ferguson RM."Improved prognosis of dysfuntional renal allografts by intensive medical therapy" . : S229
January 2000 Cosio FC, Pesavento TE, Osei , Ferguson RM."Increasing prevalence of post-transplant diabetes in renal allografts recipients treated in recent years" . : 684A
January 2000 Cosio FC, Pesavento TE, Falkenhain ME, Pelletier RP, Ferguson RM."The use of statins correlates with improved allograft survival, an effect independent of cholesterol levels" . : S365
January 2000 Spetie DN, Pesavento TE, Elkhammas EA, Hnery ML, Cosio FG."Pancreas allograft survival in simultaneous pancreas-kidney recipients: The link between K and P grafts" . : 708A
January 2000 Spetie DN, Cosio FC, Haller LU, Frankel WL, Pelletier RP, Pesavento TE."Evidence for glomerular disease during acute renal allograft rejection" . : S227
January 2000 Spetie DN, Afanasyev AY, Pesavento TE, Falkenhain ME, Ferguson RM, Cosio FG."Pyelonephritis in renal allografts is frequently clinically silent" . : 708A
January 2001 Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM."Cardiovascular risk profile in renal allograft recipients with de novo post-transplant diabetes" . : 140
January 2001 Cosio FG, Pesavento TE, Henry ML, Ferguson RM."Impact of Blood Pressure and Anti-Hypertensive Therapy on Patient Survival after Kidney Transplantation" . : 928A
January 2001 Pesavento TE, Cosio FG, Pelletier RP, Elkhammas EA, Henry ML, Ingram BS, Ferguson RM."Improved patient survival in kidney-pancreas transplant recipients treated with HMG CoA reductase inhibitors" . : 287
January 2001 Pesavento TE, Cosio FC, Falkenhain ME, Ferguson RM."Successful Treatment of Post-Transplant Membranous Nephropathy with Mycophenolate Mofetil" . : 943A
January 2002 Pesavento TE, Podoll AS, Donovan M, Hebert LA, Falkenhain ME, Cosio FC, Ferguson RM."Post-transplant bone loss: Effect of organ, era and immunosuppression" . : 294
January 2002 Pesavento TE, Henry ML, Pelletier RP, Ferguson RM."Favorable lipid profile under FYT720 immunosuppression in renal transplant recipients" . : 381
January 2002 Cosio, FC, Pesavento TE, Henry M, Ferguson RM."Kidney donor age and post-transplant hypertension: A two way street" . : 412
January 2003 Pesavento TE, Henry ML, Falkenhain MF, Ferguson RM."Post-transplant diabetes mellitus: Evidence for glucose intolerance and insulin resistance existing pre-transplant" . : 237
January 2004 Pesavento TE, Henry ML, Ferguson RM."Dismal prognosis in renal transplant allograft survival in patients with acute rejection associated with graft dysfunction" .
January 2005 Pesavento TE, Rave EM, Ferguson RM."Gastric bypass surgery as treatment of morbid obesity following transplantation: Improvement in weight and metabolic complications" . : 290
January 2005 Pesavento TE, Burdge KA, Santos JR, Patel BM, Ferguson RM."Who can provide optimal care of the diabetic renal transplant recipient: Insight from practice patterns of different providers" American Transplant Congree. : suppl 11:410
January 2006 Ferguson RM, Henry ML, Pesavento TE, Rajab A, Pelletier RP."Increasing important of C4D+ acute rejections episodes in the steroid-free era of renal transplantation" . : 639
January 2006 Pesavento TE, Davies EA, Von Visger JV, Nori U, Miller BS, Ferguson RM."Randomized, prospective withdrawal trial in kidney transplant patients treated with mycophenolate sodium comparing rapamycin vs. C2 dosed cyclosporine" . : 300
January 2007 Von Visger R, Pesavento T, Nori U."Increased mortality risk for renal transplant recipients on sirolimus and delayed graft function: A review of 74,000 patients" . : 163
January 2007 Von Visger J, Pesavento T, Nori U, Elkhammas E."Prolonged early graft dysfunction with sirolimus and association with mortality in renal transplant recipients" . : 354
January 2007 Pesavento TE, Nori U, Von Visger J, Henry ML, Ferguson RM."Sirolimus, independent of cyclosporine, is associated with worsened proteinuria in renal transplantation" . : 264
January 2007 Satoskar AA, Lehman AM, Nadasdy GM, Semak DD, Pesavento TE, Henry ML, Peletier RP, Ferguson RM, Nadasdy T.."Peritubular capillary C4d staining in late actue renal allograft rejection – is it relevant?" . : 354
January 2008 Nori US, Pesavento TE, Davies EA, Von Visger J, Miller BS, Ferguson RM."Randomized, prospective prednisone withdrawal trial in kidney transplant patients treated with sirolimus vs. microemulsified cyclosporine based regimens" . : 301
January 2009 Pesavento TE, Nori US, Satoskar A, Dils D, Henry ML, Von Visger JR, Singh N."Use of Baseline Kidney Biopsies (BX) and Pulsatile Perfusion Parameters To Predict Graft Outcome in Deceased Donor (DD) Kidney Transplants." . : 313
January 2009 Pesavento TE, Winoto J, Nori US, Von Visger JR, Singh N."Risk of Recurrent Focal Segmental Glomerulosclerosis (FSGS) in Patients Following Loss of Native Kidneys and Primary Transplant from Recurrent FSGS. Is Retransplantation Prudent?" . : 685
January 2009 Martin S, Dodson B, Bendle M, Wheeler C, Davis J, Pesavento T, Bumgardner GL."GL Monitoring. EBV Infection among Seromismatch Adult Renal Transplant Recipients." . : 460
January 2010 Kasiske B, Anderson-Haag T, Ibrahim H, Pesavento T, Nogueira J, Weir M, Cosio F, Kraus E, Rabb H, Posselt A, Muster H."Kidney Donation Causes an Increase in Serum Parathyroid Hormone Levels." . : 180
January 2010 Singh N, Gunay Y, Samavedi S, Samir P, Von Visger J, Nori U, Pesavento T, Henry M, Elkhammas E."Recurrence of IgA Nephropathy Post Kidney Transplantation in Steroid Free vs. Steroid Dependent Immunosuppression Protocol." . : 519

Presentations

"Amlodipine Increases Cyclosporine Levels in Renal Transplant Patients.." Presented at American Society of Transplant Physicians, Chicago, IL. (January 1995)

"Elevated urine collagen IV levels correlate with the severity of acture renal transplant rejection.." Presented at American Society of Transplan Physicians, Dallas, TX. (January 1996)

"Time on dialysis prior to renal transplantation correlates with patient survival post-Tx.." Presented at American Society of Transplant Physicians, Chicago, IL. (January 1997)

"Renal allograft survival in recipients of combined kidney-pancreas transplants.." Presented at American Society of Transplant Physicians, Chicago, IL. (January 1997)

"Analysis of Complications in Obese Living Kidney Donors.." Presented at American Society of Transplant Physicians, Chicago, IL. (January 1997)

"Steroid Withdrawal in Transplantation." . (October 2000)

"Medical Treatment of Allograft Nephropathy." . (October 2000)

"Nephrology in the New Millennium." . (May 2001)

"Post-transplant bone disease." . (September 2001)

"Homocysteine, Side Effects and Renal Transplantation." . (January 2002)

"Planning for Progressive Renal Disease - Transplantation Options." . (September 2002)

"Renal Transplantation Advances." . (April 2003)

"Transplant survival and the effect of dialysis." . (May 2003)

"Organ Transplantation and Transplant Immunology." . (April 2005)

"Renal Transplantation." . (March 2005)

"Renal Dysfunction in Liver Transplant Recipients: Transplant Nephrology Perspective." . (April 2007)

"Cardio Renal Syndrome." . (November 2007)

"Diabetes and Transplantation." . (September 2007)

"Risk Index: Life Years Following Transplant." Boston, MA. (August 2008)

"Factors Affecting Kidney Sharing and Graft Survival, Effect of New Organ Allocation Proposal." . (April 2008)

"Allocation of Deceased Donor Organs for Renal Transplantation." . (November 2008)

"Use of Baseline Kidney Biopsies (BX) and Pulsatile Perfusion Parameters To Predict Graft Outcome in Deceased Donor (DD) Kidney Transplants.." Presented at ATC 2009, . (January 2009)

"Risk of Recurrent Focal Segmental Glomerulosclerosis (FSGS) in Patients Following Loss of Native Kidneys and Primary Transplant from Recurrent FSGS. Is Retransplantation Prudent?." Presented at ATC 2009, . (January 2009)

"GL Monitoring. EBV Infection among Seromismatch Adult Renal Transplant Recipients.(DD) Kidney Transplants.." Presented at ATC 2009, . (January 2009)

"Lack of early CSA exposure after kidney transplantation is a significant risk factor for de novo post-transplant alloantibody production in African-American recipients." Presented at ATC 2011, . (January 2011)

"Incidence of immunologic complications after renal transplantation, when using a steroid avoidance, Neoral and Sirolimus immunosuppression regimen, is increased in African-American recipients." Presented at ATC 2011, . (January 2011)

"Clinical variables predictive of 1 and 3 year recipient survival at a single center." Presented at ATC 2011, . (January 2011)

"Living donor transplant mitigates the adverse impact of diabetes status in elderly (>65 years) kidney transplant recipients.." Presented at ATC 2011, . (January 2011)

"Higher Systolic Blood Pressure Is Associated with Increased Cardiovascular Risk in Patients with Hypertension in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial." Presented at ATC 2011, . (January 2011)

 

Professional Activities

2000 - present Medical Treatment of Allograft Nephropathy. North Carolina Nephrology.
2001 - present Steroid Withdrawal in Transplantation. University of North Carolina Transplant Program.
2001 - present Nephrology in the New Millennium. National Kidney Foundation of Ohio Annual Meeting.
2001 - present Post-transplant bone disease. Midwest Region United Network for Organ Sharing Annual Meeting.
2002 - present Homocysteine, Side Effects and Renal Transplantation. NIH Multicenter Research Study Group for FAVORIT.
2002 - present Planning for Progressive Renal Disease - Transplantation Options. Nephrology Continuing Medical Education Program.
2003 - present Renal Transplantation Advances. Internal Medicine Grand Rounds. Columbus, OH.
2003 - present Transplant survival and the effect of dialysis. National Kidney Foundation of Ohio Annual Meeting.
2005 - present Organ Transplantation and Transplant Immunology. Susac’s Syndrome Symposium. Columbus, OH.
2005 - present Renal Transplantation. Internal Medicine Grand Rounds. Columbus, OH.
2007 - present Renal Dysfunction in Liver Transplant Recipients: Transplant Nephrology Perspective. Ohio Solid Organ Transplant Consortium, Liver Professional Transplant Symposium.
2007 - present Diabetes and Transplantation. Diabetes Dialogue: Diabetes and Transplantation. Columbus, OH.
2007 - present Cardio Renal Syndrome. Sixth Annual Heart Failure Update Symposium. Columbus, OH.
2008 - present Factors Affecting Kidney Sharing and Graft Survival, Effect of New Organ Allocation Proposal. Life Connection of Ohio Organ and Tissue Transplantation, Spring Forum.
2008 - present Allocation of Deceased Donor Organs for Renal Transplantation. American Society of Nephrology Annual Meeting. Philadelphia, PA.
2008 - present Risk Index: Life Years Following Transplant. NATCO Annual Meeting. Boston, MA.
2011 - present Genzyme Corporation.
2011 - present Novartis Pharmaceutical.
2011 - present Medical Student Scholarship Program.
2011 - present Astellas Pharma.
2011 - present Wyeth Pharmaceutical.
2011 - present Ortho Biotech, Inc.
2011 - present External Review of Transplant Program and Strategic Plan. University if Illinois.